GS
EW icon

GTS Securities’s Edwards Lifesciences EW Stock Holding History

GTS Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71,100
Closed -$4.69M – 2174
2024
Q3 		$4.69M Buy
71,100
+62,000
+681% +$4.5M 0.01% 934
2024
Q2 		$841K Sell
9,100
-18,500
-67% -$1.64M ﹤0.01% 2220
2024
Q1 		$2.64M Sell
27,600
-15,800
-36% -$1.33M ﹤0.01% 1293
2023
Q4 		$3.31M Buy
43,400
+5,500
+15% +$383K 0.01% 1290
2023
Q3 		$2.63M Buy
+37,900
New +$3.05M ﹤0.01% 1314

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GTS Securities's EW Position: Q1 2026 in Review

GTS Securities reduced its Edwards Lifesciences (EW) stake by 11% in Q1 2026, selling an estimated $50.8K and leaving 4,847 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #911.

GTS Securities first reported a position in EW in Q3 2023 and has held it in 8 quarters since. The position peaked at $2.17M in Q4 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • GTS Securities held 4,847 shares of Edwards Lifesciences worth $388K as of Q1 2026.
  • GTS Securities sold 616 Edwards Lifesciences shares in Q1 2026, an estimated $50.8K.
  • Edwards Lifesciences made up 0.01% of GTS Securities's portfolio in Q1 2026, its #911 holding.
  • GTS Securities first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 8 quarters since.
  • GTS Securities's Edwards Lifesciences position peaked at $2.17M in Q4 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.